Cargando…
Stroke as a Potential Complication of COVID-19-Associated Coagulopathy: A Narrative and Systematic Review of the Literature
Coronavirus disease 2019 (COVID-19) is the most overwhelming medical threat of the past few decades. The infection, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), can cause serious illness leading to respiratory insufficiency, and, in severely ill patients, it can progress t...
Autores principales: | Szegedi, István, Orbán-Kálmándi, Rita, Csiba, László, Bagoly, Zsuzsa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7599722/ https://www.ncbi.nlm.nih.gov/pubmed/32998398 http://dx.doi.org/10.3390/jcm9103137 |
Ejemplares similares
-
Markers of Coagulation and Fibrinolysis Predicting the Outcome of Acute Ischemic Stroke Thrombolysis Treatment: A Review of the Literature
por: Bagoly, Zsuzsa, et al.
Publicado: (2019) -
Incorporation of α2-Plasmin Inhibitor into Fibrin Clots and Its Association with the Clinical Outcome of Acute Ischemic Stroke Patients
por: Bagoly, Zsuzsa, et al.
Publicado: (2021) -
A modified in vitro clot lysis assay predicts outcomes and safety in acute ischemic stroke patients undergoing intravenous thrombolysis
por: Orbán-Kálmándi, Rita, et al.
Publicado: (2021) -
High Neutrophil–Lymphocyte Ratio and Low Lymphocyte–Monocyte Ratio Combination after Thrombolysis Is a Potential Predictor of Poor Functional Outcome of Acute Ischemic Stroke
por: Sadeghi, Farzaneh, et al.
Publicado: (2022) -
Decreased clot burden is associated with factor XIII Val34Leu polymorphism and better functional outcomes in acute ischemic stroke patients treated with intravenous thrombolysis
por: Szegedi, István, et al.
Publicado: (2021)